Intuitive Surgical’s (ISRG) Overweight Rating Reiterated at Piper Sandler

Intuitive Surgical (NASDAQ:ISRG)‘s stock had its “overweight” rating reissued by Piper Sandler in a note issued to investors on Friday,Benzinga reports. They presently have a $670.00 price target on the medical equipment provider’s stock, up from their previous price target of $538.00. Piper Sandler’s target price would indicate a potential upside of 14.38% from the stock’s previous close.

A number of other analysts also recently issued reports on ISRG. Truist Financial lifted their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $574.17.

Intuitive Surgical Trading Down 3.8 %

Shares of ISRG traded down $22.89 during mid-day trading on Friday, reaching $585.77. 2,491,103 shares of the stock traded hands, compared to its average volume of 1,867,070. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $208.64 billion, a price-to-earnings ratio of 94.39, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm has a fifty day moving average price of $546.03 and a 200 day moving average price of $503.38.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock worth $22,070,807 over the last ninety days. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently added to or reduced their stakes in the business. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter valued at about $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.